Aurobindo's generic Cosopt is a treatment for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers.
Dorzolamide hydrochloride and timolol maleate ophthalmic solution has a market value of roughly $80 million for the 12 months ended December 2020, according to IQVIA.